Thanks Percy, my home made clinical trial will begin when the postman delivers. In an earlier post Peat mentioned Promisia and Arthrem. I had tried it but did not find it helpful.
Printable View
Annual report now available
https://www.usx.co.nz/uploads/paperc...pdf?1587535665
Thanks for the link.
The fun continues.
"Accordingly, we will continue with the next phase of our capital
expansion program which will see up to $8 million invested
in key projects over the next year to provide additional
capacity and bring new products to market. They will be
funded from a combination of operating cash flow and bank
debt.
Once fully operational, these projects are expected to provide
a strong return on investment and positive ongoing margin
contributions."
Another huge freeze drier included..
"PharmaZen is now firmly established on a cash-positive
growth path, with increasing demand being well supported
by efficient, quality manufacturing. This momentum places
the Company in an excellent position to look further ahead
and capture future growth opportunities as they arise. We are
moving forward with considerable optimism."
Glucosamine did not help either. Voltaren helps but I am trying to cut down on that.
Bean counters are notorious for concentrating on cash flow, (and with good reason as this is the lifeblood of any business).
A real highlight for me on my first real quick skim read this morning (of the many encouraging aspects of the growth of this company) is the near tripling of cash flow ! This augers extremely well for the future.
I am favourably inclined to add more. Historic PE at 26 cents is 19.8 and this company is growing at a cracking pace, this year assisted by tailwinds from the currency and a full year sales effect of the recently launched Aiora range. Things will really be humming when they launch their new brand "5th quarter" which is quite an interesting brand name.
I noted current assets consisted largely of receivables and cash on hand was down (this was eoy2019 so way before CV19) it just looked a little stretched to me in terms of the quality of the current ratio.